A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry

Molecular Psychiatry

Volumn 7, Issue 6, 2002, Pages 617-625

  Nordstrom, E J ^a   Burton, F H ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

ADD; ADHD; D1 receptor; Dopamine; Gender; Glutamate; Norepinephrine; OCD; Serotonin; Somatosensory; Tourette; Trichotillomania

Indexed keywords

CLONIDINE; DOPAMINE 1 RECEPTOR; GLUTAMATE RECEPTOR; ANALGESIC AGENT; CHOLERA TOXIN;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BEHAVIOR DISORDER; BITE; COMORBIDITY; COMPULSION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; DISEASE SEVERITY; DOPAMINE RELEASE; EFFERENT NERVE; GENDER; GILLES DE LA TOURETTE SYNDROME; GROOMING; HEREDITY; HYPERACTIVITY; LIMBIC CORTEX; MOUSE; NERVE CELL; NERVE CELL EXCITABILITY; NEUROTRANSMISSION; NONHUMAN; OBSESSION; ORBITAL CORTEX; PERSEVERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSORIMOTOR CORTEX; STRIATE CORTEX; TIC; TRANSGENIC ANIMAL; ANIMAL; DRUG EFFECT; FEMALE; GENETICS; INCIDENCE; MALE; MOTOR ACTIVITY; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; SEXUAL DEVELOPMENT; TRANSGENIC MOUSE;

ANALGESICS; ANIMAL; CHOLERA TOXIN; CLONIDINE; COMORBIDITY; FEMALE; INCIDENCE; MALE; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; OBSESSIVE-COMPULSIVE DISORDER; RECEPTORS, DOPAMINE D1; SEX CHARACTERISTICS; SUPPORT, NON-U.S. GOV'T; TICS; TOURETTE SYNDROME; ANIMALS;

EID: 0036342770     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001144     Document Type: Article

References (48)

1. The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission
2. Tourette syndrome and other tic disorders. Diagnosis, pathophysiology, and treatment
3. PANDAS: The search for environmental triggers of pediatric neuropsychiatric disorders. Lessons from rheumatic fever
4. Tics and Tourette's disorder: A 2- to 7-year follow-up of 54 obsessive-compulsive children
5. Obsessions and compulsions in Gilles de la Tourette's syndrome
6. The potential role of haloperidol in the treatment of trichotillomania
7. Definitions and classification of tic disorders
8. Tourette's and comorbid syndromes: Obsessive compulsive and attention deficit hyperactivity disorder. A common etiology?
9. Neurosurgical treatment of severe obsessive-compulsive disorder associated with Tourette's syndrome
10. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy
11. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder
12. Altered cortical excitability in obsessive-compulsive disorder
13. Decreased motor inhibition in Tourette's disorder: Evidence from transcranial magnetic stimulation
14. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine
15. Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: Evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons
16. 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites
17. Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release
18. Pharmacotherapy of Tourette's syndrome and associated disorders
19. OCD-Like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons
20. Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene
21. Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain
22. Behavioral effects of cocaine on a transgenic mouse model of cortical-limbic compulsion
23. Anxiety in a transgenic mouse model of cortical-limbic neuropotentiated compulsive behavior
24. The role of cognitive and affective processing in a transgenic mouse model of cortical-limbic neuropotentiated compulsive behavior
25. Parallel organization of functionally segregated circuits linking basal ganglia and cortex
26. Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration
27. Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: Behavioral findings
28. Tourette syndrome: Prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding
29. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome
30. Alpha2-Adrenoceptor antagonists reverse the 5-HT2 receptor antagonist suppression of head-twitch behavior in mice
31. Differential response of cortical-limbic neuropotentiated compulsive mice to dopamine D1 and D2 receptor antagonists
32. Neuropsychiatric disorders of childhood: Tourette's syndrome as a model
33. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever
34. Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette's syndrome
35. Predictors of clonidine response in Tourette syndrome: Implications and inferences
36. TS+OCD-like neuropotentiated mice are supersensitive to seizure induction
37. Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's Syndrome and obsessive-compulsive disorder
38. Experiments using transcranial magnetic brain stimulation in man could reveal important new mechanisms in motor control
39. Management of Gilles de la Tourette syndrome using sulpiride
40. Treatment of refractory OCD with the dopamine agonist bromocriptine
41. Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial
42. Ketanserin treatment of Tourette's syndrome in children
43. Action sequencing is impaired in D1A-deficient mutant mice
44. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: Effects of stimulant and dose
45. An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder
46. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study
47. On the role of cortical glutamate in obsessive-compulsive disorder and attention-deficit hyperactivity disorder, two phenomenologically antithetical conditions